...
首页> 外文期刊>World Journal of Gastroenterology >Mitochondrial metabolomic profiling for elucidating the alleviating potential of Polygonatum kingianum against high-fat diet-induced nonalcoholic fatty liver disease
【24h】

Mitochondrial metabolomic profiling for elucidating the alleviating potential of Polygonatum kingianum against high-fat diet-induced nonalcoholic fatty liver disease

机译:用于阐明泛脂致毒性的非酒精性脂肪肝疾病的多葡聚糖吉尼姆的缓解潜力的线粒体代谢物质分析

获取原文
   

获取外文期刊封面封底 >>

       

摘要

BACKGROUND:Developing mitochondrial regulators/nutrients from natural products to remedy mitochondrial dysfunction represent attractive strategies for therapy of non-alcoholic fatty liver disease (NAFLD). Polygonatum kingianum (PK) has been traditionally used in China as a medicinal and nutritional ingredient for centuries and can alleviate high-fat diet (HFD)-induced NAFLD by promoting mitochondrial functions. To date, the underlying molecular mechanism of PK for treating mitochondrial dysfunctions and thus alleviating NAFLD remains unclear.AIM:To identify the molecular mechanism behind the mitochondrial regulatory action of PK against HFD-induced NAFLD in rats.METHODS:NAFLD model was induced in rats with HFD. The rats were intragastrically administered PK (4 g/kg per day) for 14 wk. Metabolites in hepatic mitochondrial samples were profiled through ultra-high performance liquid chromatography/mass spectrometry followed by multivariate statistical analysis to find the potential biomarkers and metabolic pathways.RESULTS:PK significantly restored the metabolites' levels in the mitochondrial samples. Ten potential biomarkers were identified in the analyzed samples. These biomarkers are involved in riboflavin metabolism.CONCLUSION:PK can alleviate HFD-induced NAFLD by regulating the riboflavin metabolism and further improving the mitochondrial functions. Thus, PK is a promising mitochondrial regulator/nutrient for alleviating NAFLD-associated diseases.?The Author(s) 2019. Published by Baishideng Publishing Group Inc. All rights reserved.
机译:背景技术:从天然产物开发线粒体调节剂/营养素以补救线粒体功能障碍代表非酒精性脂肪肝病(NAFLD)治疗的吸引力策略。多尼戈尼昂吉安姆(PK)传统上用于中国的药物和营养成分,通过促进线粒体功能来缓解高脂饮食(HFD)诱导的NAFLD。迄今为止,PK治疗线粒体功能障碍的潜在分子机制,从而减轻NAFLD仍然不清楚.Aught:以鉴定PK对大鼠HFD诱导的NAFLD的线粒体调控作用背后的分子机制。方法:NAFLD模型在大鼠中诱发NAFLD模型用氢铅。大鼠胃内施用PK(每天4g / kg)14周。通过超高效液相色谱/质谱分析肝线粒体样品中的代谢物,然后通过多变量统计分析来寻找潜在的生物标志物和代谢途径。结果:PK显着恢复了线粒体样本中的代谢物水平。在分析的样品中鉴定了十个潜在的生物标志物。这些生物标志物涉及核黄素代谢。结论:通过调节核黄素代谢并进一步改善线粒体功能,PK可以缓解HFD诱导的NAFLD。因此,PK是一种有前途的线粒体调节因子/营养素,用于缓解NAFLD相关疾病。2019年作者。由Baishideng Publishing Group Inc.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号